Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

NCT06036784 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Postbariatric Hypoglycemia

Interventions

DRUG: MBX 1416 (Part A)
DRUG: MBX 1416 (Part B)
DRUG: Placebo
DRUG: MBX 1416 (Part C)

Sponsor

MBX Biosciences

Collaborators

[object Object]